Search
macimorelin (Macrilen)
Indications:
- diagnosis of adult growth hormone deficiency
Dosage:
- 0.5 mg/kg PO single dose after fasting for at least 8 hours
Mechanism of action:
- ghrelin agonist
- stimulates secretion of growth hormone from the pituitary
General
endocrine agent
References
- Windle ML.
FDA New Drug and Biologic Approvals -- 2017 Year-in-Review
Medscape - Jan 11, 2018.
https://reference.medscape.com/viewarticle/890871
- U.S. Food and Drug Administration.
Novel Drug Approvals for 2017.
https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm537040.htm
- Macrilen (macimorelin) prescribing information.
Aeterna Zentaris. Frankfurt am Main, Germany. December, 2017.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205598s000lbl.pdf